Introduction
============

We recently proposed a set of provisional, evidence-based, clinical criteria for the classification of children and adults patients affected by monogenic periodic fevers. These criteria, built and validated in a cohort of 1215 patients with periodic fever enrolled in the Eurofever Registry from November 2009 to February 2013, displayed a high sensitivity and specificity.

Objectives
==========

To prospectively validate the provisional Eurofever clinical classification criteria in an independent set of patients with periodic fevers enrolled in the registry after March 2013

Methods
=======

The provisional Eurofever classification criteria (best accuracy cut-off) were applied to patients with periodic fevers enrolled in the registry after March 2013. The following disease were analyzed: FMF, MKD, TRAPS, CAPS, PFAPA and undefined periodic fevers. Patients were divided in three subgroups: i) group A: inherited periodic fevers with genetic confirmation, ii) group B: inherited periodic fevers with non-confirmatory genetic test, iii) group C: negative controls. Statistical analysis compared the sensitivity and specificity of best accuracy cut-off in patients belonging to group A and C.

Results
=======

A total of 245 patients were evaluated. Among them 80 were classified in group A (35 FMF, 28 MKD, 9 TRAPS, 8 CAPS), 94 in group B (56 FMF, 6 MKD, 9 TRAPS, 23 CAPS) and 71 in group C (59 PFAPA and 12 undefined periodic fever). The classification criteria tested on patients belonging to Group A and C displayed an overall good sensitivity and specificity (respectively 85% and 92% for FMF, 92% and 89% for MKD, 100% and 96% for CAPS and 100% and 93% for TRAPS). (see table [1](#T1){ref-type="table"}). The performance of the classification criteria in patients with non- confirmatory genetic test are reported in Table [1](#T1){ref-type="table"} below.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------
                                        Sensitivity\              Specificity\                                                                    
                                        (Best Accuracy cut-off)   (Best Accuracy cut-off)                                                         
  ------------------------------------- ------------------------- ------------------------- ---------- ----------- --------- --------- ---------- -----------
                                        **FMF**                   **MKD**                   **CAPS**   **TRAPS**   **FMF**   **MKD**   **CAPS**   **TRAPS**

                                                                                                                                                  

  Genetically confirmed (Group A)       85%                       92%                       100%       100%        92%       89%       96%        93%

                                                                                                                                                  

  Not genetically confirmed (Group B)   58%                       67%                       45%        25%         94%       79%       100%       82%
  -----------------------------------------------------------------------------------------------------------------------------------------------------------

Conclusion
==========

Perspective validation of Eurofever classification criteria showed their good accuracy in patients with confirmatory genetic test. Despite a lower sensitivity, the criteria displayed an high specificity in the classification of patients with non-confirmatory molecular test. In order to evaluate the actual accuracy of the classification criteria in this latter subgroup, an expert validation is currently ongoing.
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